Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

JAK inhibitors show promise for treating various skin diseases.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Women with female pattern hair loss have lower Vitamin D3 levels.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.